Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment

被引：0
|
作者：
I Michels
S Staszewski
L Gürtler
G Nisius
A Müller
L Locher
H-W Doerr
M Stürmer
机构：
[1] Institute for Medical Virology,J.W.Goethe University Hospital
[2] Department of Internal Medicine II,J.W.Goethe University Hospital, Medical HIV Treatment and Research Unit
[3] Infektiologikum Frankfurt-Sachsenhausen,undefined
[4] Infektiologikum Frankfurt-City,undefined
来源：
European Journal of Medical Research | / 15卷
关键词：
antiretroviral therapy; genotypic resistance; reverse transcriptase; polymerase; RNase H; connection domain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Genetic Diversity and Drug Resistance Mutations in Reverse Transcriptase and Protease Genes of HIV-1 Isolates from Southwestern Siberia
    Rudometova, Nadezhda B.
    Shcherbakova, Nadezhda S.
    Shcherbakov, Dmitry N.
    Mishenova, Elena V.
    Delgado, Elena
    Ilyichev, Alexander A.
    Karpenko, Larisa I.
    Thomson, Michael M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (09) : 716 - 723
  • [42] Impact of HIV-1 reverse transcriptase E138 mutations on rilpivirine drug susceptibility
    Haddad, M.
    Napolitano, L. A.
    Paquet, A. C.
    Evans, M. C.
    Petropoulos, C. J.
    Whitcomb, J.
    Rimsky, L.
    Vingerhoets, J.
    Picchio, G.
    Coakley, E.
    ANTIVIRAL THERAPY, 2011, 16 : A18 - A18
  • [43] Novel recombinant phenotypic assay for clonal analysis of reverse transcriptase mutations conferring drug resistance to HIV-1 variants
    Paolucci, S
    Baldanti, F
    Zavattoni, M
    Gerna, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 766 - 771
  • [44] HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naive HIV-infected individuals
    Bokharaei-Salim, Farah
    Esghaei, Maryam
    Khanaliha, Khadijeh
    Kalantari, Saeed
    Marjani, Arezoo
    Fakhim, Atousa
    Keyvani, Hossein
    PLOS ONE, 2020, 15 (03):
  • [45] Prevalence of atypical mutations at codon 215 of HIV-1 reverse transcriptase
    Cane, P
    Rehman, Y
    Porter, K
    Pillay, D
    ANTIVIRAL THERAPY, 2002, 7 : S60 - S60
  • [46] Involvement of novel HIV-1 reverse transcriptase mutations in the highly ordered regulation of NRTI resistance
    Ceccherini-Silberstein, F
    Svicher, V
    Sing, T
    Santoro, M
    Beerenwinkel, N
    Gago, F
    Bertoli, A
    Forbici, F
    Bellocchi, MC
    Narciso, P
    Monforte, AD
    Antinori, A
    Perno, CF
    ANTIVIRAL THERAPY, 2005, 10 : S106 - S106
  • [47] Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1
    Turner, D
    Brenner, B
    Wainberg, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 53 - 57
  • [48] Chemometrical identification of mutations in HIV-1 reverse transcriptase conferring resistance or enhanced sensitivity to arylsulfonylbenzonitriles
    Rodríguez-Barrios, F
    Gago, F
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (09) : 2718 - 2719
  • [49] Involvement of novel HIV-1 reverse transcriptase mutations in the highly ordered regulation of NRTI resistance
    Ceccherini-Silberstein, F
    Svicher, V
    Sing, T
    Santoro, M
    Beerenwinkel, N
    Gago, F
    Bertoli, A
    Forbici, F
    Bellocchi, MC
    Narciso, P
    d'Arminio Monforte, A
    Antinori, A
    Perno, CF
    ANTIVIRAL THERAPY, 2005, 10 (04) : S106 - S106
  • [50] Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase
    Isaguliants, MG
    Belikov, SV
    Starodubova, ES
    Gizatullin, RZ
    Rollman, E
    Zuber, B
    Zuber, AK
    Andreeva, OI
    Rytting, AS
    Källander, CFR
    Kochetkov, SN
    Karpov, VL
    Wahren, B
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (02) : 191 - 201
12345